What is the clinical evidence from this study?

Study design: Review. Population: Congenital heart disease. Intervention: Implantable cardioverter-defibrillator (ICD) therapy.

What question did this study set out to answer?

Review contemporary evidence regarding the utilization of implantable cardioverter-defibrillators in patients with congenital heart disease, with a focus on novel implantation methodologies.

January 22, 2008Pacing and Clinical Electrophysiology

Practical Aspects of Implantable Defibrillator Therapy in Patients with Congenital Heart Disease

View Full Paper

Ask AI

Bookmark

Key result

A review of contemporary data on implantable cardioverter-defibrillator use in patients with congenital heart disease highlights clinical challenges in patient selection and novel implant methodologies.

Population

Patients with congenital heart disease (CHD) at risk for malignant ventricular arrhythmias

Design

Review

Authors

EWEdward P. WalshElectrophysiology

Discussion

Member takes

Implication

May guide cautious ICD decisions in congenital heart disease; leaves open prospective validation of novel implant strategies.

Key Points

Review contemporary evidence regarding the utilization of implantable cardioverter-defibrillators in patients with congenital heart disease, with a focus on novel implantation methodologies.
Synthesized contemporary literature on implantable cardioverter-defibrillator therapy across the congenital heart disease population.
Evaluated clinical challenges related to risk stratification, patient selection, and anatomical obstacles to standard transvenous lead positioning.
Identified complex cardiac morphology and vascular anomalies as the primary barriers complicating standard lead placement and increasing procedural risk.
Highlighted the adoption and utility of alternative, non-traditional implantation techniques to achieve effective defibrillation without compromising structurally altered anatomy.

Structured PICO

Population

Patients with congenital heart disease (CHD) at risk for malignant ventricular arrhythmias

Intervention

Implantable cardioverter-defibrillator (ICD) therapy and novel implant methodology

This review highlights contemporary data and clinical challenges regarding patient selection and novel implant methodologies for ICD therapy in patients with congenital heart disease.

Cite This Study

Edward P. Walsh (2008) conducted a review in Congenital heart disease. Implantable cardioverter-defibrillator (ICD) therapy was evaluated. A review of contemporary data on implantable cardioverter-defibrillator use in patients with congenital heart disease highlights clinical challenges in patient selection and novel implant methodologies.

synapsesocial.com/papers/6a71c56ec2d7c30908271e51 https://doi.org/10.1111/j.1540-8159.2008.00954.x

Topics

Cardiac device therapy Congenital heart disease adults Heart failure HFrEF treatment

View Full Paper

Ask AI

Bookmark

Practical Aspects of Implantable Defibrillator Therapy in Patients with Congenital Heart Disease

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Practical Aspects of Implantable Defibrillator Therapy in Patients with Congenital Heart Disease

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider